Abstract:Focal cortical dysplasia (FCD) type II is a highly epileptogenic developmental malformation and a common cause of surgically treated drug-resistant epilepsy. While clinical observations suggest frequent occurrence in the frontal lobe, mechanisms for such propensity remain unexplored. Here, we hypothesized that cortex-wide spatial associations of FCD distribution with cortical cytoarchitecture, gene expression and organizational axes may offer complementary insights into processes that predispose given cortical regions to harbor FCD. We mapped the cortex-wide MRI distribution of FCDs in 337 patients collected from 13 sites worldwide. We then determined its associations with 1) cytoarchitectural features using histological atlases by Von Economo and Koskinas and BigBrain, 2) whole-brain gene expression and spatiotemporal dynamics from prenatal to adulthood stages using the Allen Human Brain Atlas and PsychENCODE BrainSpan and 3) macroscale developmental axes of cortical organization. FCD lesions were preferentially located in the prefrontal and fronto-limbic cortices typified by low neuron density, large soma and thick gray matter. Transcriptomic associations with FCD distribution uncovered a prenatal component related to neuroglial proliferation and differentiation, likely accounting for the dysplastic makeup, and a postnatal component related to synaptogenesis and circuit organization, possibly contributing to circuit-level hyperexcitability. FCD distribution showed a strong association with the anterior region of the antero-posterior axis derived from heritability analysis of inter-regional structural covariance of cortical thickness, but not with structural and functional hierarchical axes. Reliability of all results was confirmed through resampling techniques. Multimodal associations with cytoarchitecture, gene expression and axes of cortical organization indicates that prenatal neurogenesis and postnatal synaptogenesis may be key points of developmental vulnerability of the frontal lobe to FCD. Concordant with a causal role of atypical neuroglial proliferation and growth, our results indicate that FCD-vulnerable cortices display properties indicative of earlier termination of neurogenesis and initiation of cell growth. They also suggest a potential contribution of aberrant postnatal synaptogenesis and circuit development to FCD epileptogenicity.

The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by <i>MTOR</i> mosaicism

The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by MTOR mosaicism

Somatic Variants in New Candidate Genes Identified in Focal Cortical Dysplasia Type II

Deep histopathology genotype-phenotype analysis of focal cortical dysplasia type II differentiates between the GATOR1-altered autophagocytic subtype IIa and MTOR-altered migration deficient subtype IIb

Spatial omics reveals molecular changes in focal cortical dysplasia type II

Identification of Genetic Characteristics in Pediatric Epilepsy with Focal Cortical Dysplasia Type 2 Using Deep Whole-Exome Sequencing

Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N‐methyl‐D‐aspartate receptors

Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia

Rational Search for Genes in Familial Cortical Myoclonic Tremor with Epilepsy, Clues from Recent Advances.

Spatial transcriptomics in focal cortical dysplasia type IIb

Focal cortical dysplasia II caused by brain somatic mutation of IRS-1 is associated with ERK signaling pathway activation

Automated Detection of Focal Cortical Dysplasia Type II with Surface-Based Magnetic Resonance Imaging Postprocessing and Machine Learning

ILAE genetic literacy series: Focal cortical dysplasia

GABAergic Interneuron and Neurotransmission Are Mtor-Dependently Disturbed in Experimental Focal Cortical Dysplasia

Multimodal single-cell profiling reveals neuronal vulnerability and pathological cell states in focal cortical dysplasia

Contribution of the Activated mTOR-STAT3 Pathway to the Pathogenesis of Focal Cortical Dysplasia Type IIIa in Pediatric Patients through Astrocyte Proliferation Mediation

Identification of a mosaic MTOR variant in purified neuronal DNA in a patient with focal cortical dysplasia using a novel depth electrode harvesting technique

Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients

Multimodal mapping of regional brain vulnerability to focal cortical dysplasia

A Brain Somatic RHEB Doublet Mutation Causes Focal Cortical Dysplasia Type II.

Diagnostic methods and treatment options for focal cortical dysplasia